Literature DB >> 1910294

Purification and immunological characterization of a novel cytochrome P450 from C3H/10T1/2 cells.

L H Pottenger1, M Christou, C R Jefcoate.   

Abstract

The major polycyclic aromatic hydrocarbon-metabolizing cytochrome P450 in the mouse embryo fibroblast-derived C3H/10T1/2 CL8 cell line (P450-EF) has been partially purified from benz[a]anthracene (BA)-induced 10T1/2 cells (40 pmol P450/mg). The purification of P450-EF was carried out by sequential chromatography of solubilized microsomes over hydrophobic aminohexyl-Sepharose 4B, anion exchange DE-52 cellulose, and cation exchange carboxymethyl trisacryl columns. The final preparation (1700 pmol/mg) appeared as a single major 55-kDa band by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Reconstitution of detergent-free partially purified P450-EF yielded a relatively high turnover for 7,12-dimethylbenz[a]anthracene (DMBA) metabolism (5.4 nmol/nmol/min). Polyclonal antibodies to purified P450-EF (anti-P450-EF), raised in, respectively, rabbit and chicken, detected a single 55-kDa band in 10T1/2 cell microsomes that was highly inducible by BA (approximately 20-fold) and TCDD (approximately 5-fold). Rabbit anti-P450-EF was much more effective than the corresponding chicken antibody at binding denatured P450-EF protein on Western blots. Conversely, only the chicken antibody was effective at inhibiting DMBA metabolism catalyzed by microsomal P450-EF. This antibody did not inhibit P450IA1-mediated DMBA metabolism. Rabbit anti-P450-EF recognized very weakly (less than 1% of homologous protein response) pure P450IA1, IIB1, IIC7, IIE1, and IIIA1 proteins on Western blots but exhibited substantial cross-reactivity (approximately 10%) with pure P450IIA1 and very strong cross-reactivity (approximately 75%) with a hormonally regulated rat adrenal P450. Polyclonal antibodies to several major P450 subfamilies either did not recognize P450-EF (anti-P450IA, IIB, and IIC) or recognized it very weakly (anti-P450IIA1). P450-EF is probably distantly related to the P450IIA subfamily and may belong to a new P450 subfamily.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1910294     DOI: 10.1016/0003-9861(91)90070-y

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  8 in total

1.  Cytochrome P450 CYP1B1 determines susceptibility to 7, 12-dimethylbenz[a]anthracene-induced lymphomas.

Authors:  J T Buters; S Sakai; T Richter; T Pineau; D L Alexander; U Savas; J Doehmer; J M Ward; C R Jefcoate; F J Gonzalez
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

Review 2.  Potential role of CYP1B1 in the development and treatment of metabolic diseases.

Authors:  Fei Li; Weifeng Zhu; Frank J Gonzalez
Journal:  Pharmacol Ther       Date:  2017-03-16       Impact factor: 12.310

3.  Langerhans cells facilitate epithelial DNA damage and squamous cell carcinoma.

Authors:  Badri G Modi; Jason Neustadter; Elisa Binda; Julia Lewis; Renata B Filler; Scott J Roberts; Bernice Y Kwong; Swapna Reddy; John D Overton; Anjela Galan; Robert Tigelaar; Lining Cai; Peter Fu; Mark Shlomchik; Daniel H Kaplan; Adrian Hayday; Michael Girardi
Journal:  Science       Date:  2012-01-06       Impact factor: 47.728

4.  Identification of a cytochrome P450 gene by reverse transcription--PCR using degenerate primers containing inosine.

Authors:  Z Shen; R L Wells; J Liu; M M Elkind
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

5.  Mitochondrial targeting of mouse NQO1 and CYP1B1 proteins.

Authors:  Hongbin Dong; Howard G Shertzer; Mary Beth Genter; Frank J Gonzalez; Vasilis Vasiliou; Colin Jefcoate; Daniel W Nebert
Journal:  Biochem Biophys Res Commun       Date:  2013-05-18       Impact factor: 3.575

6.  4-Hydroxylation of estradiol by human uterine myometrium and myoma microsomes: implications for the mechanism of uterine tumorigenesis.

Authors:  J G Liehr; M J Ricci; C R Jefcoate; E V Hannigan; J A Hokanson; B T Zhu
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

7.  CYP1B1 as a therapeutic target in cardio-oncology.

Authors:  Alexa N Carrera; Marianne K O Grant; Beshay N Zordoky
Journal:  Clin Sci (Lond)       Date:  2020-11-13       Impact factor: 6.124

Review 8.  Cytochrome P450 1B1: A Key Regulator of Ocular Iron Homeostasis and Oxidative Stress.

Authors:  Yong-Seok Song; Andrew J Annalora; Craig B Marcus; Colin R Jefcoate; Christine M Sorenson; Nader Sheibani
Journal:  Cells       Date:  2022-09-20       Impact factor: 7.666

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.